From seabed to bedside: A review on promising marine anticancer compounds

Edina Wang, Maria Alba Sorolla, Priya Darshini Gopal Krishnan, Anabel Sorolla

Research output: Contribution to journalReview article

6 Citations (Scopus)


The marine environment represents an outstanding source of antitumoral compounds and, at the same time, remains highly unexplored. Organisms living in the sea synthesize a wide variety of chemicals used as defense mechanisms. Interestingly, a large number of these compounds exert excellent antitumoral properties and have been developed as promising anticancer drugs that have later been approved or are currently under validation in clinical trials. However, due to the high need for these compounds, new methodologies ensuring its sustainable supply are required. Also, optimization of marine bioactives is an important step for their success in the clinical setting. Such optimization involves chemical modifications to improve their half-life in circulation, potency and tumor selectivity. In this review, we outline the most promising marine bioactives that have been investigated in cancer models and/or tested in patients as anticancer agents. Moreover, we describe the current state of development of anticancer marine compounds and discuss their therapeutic limitations as well as different strategies used to overcome these limitations. The search for new marine antitumoral agents together with novel identification and chemical engineering approaches open the door for novel, more specific and efficient therapeutic agents for cancer treatment.

Original languageEnglish
Article number248
Issue number2
Publication statusPublished - 1 Feb 2020


Dive into the research topics of 'From seabed to bedside: A review on promising marine anticancer compounds'. Together they form a unique fingerprint.

Cite this